USPTO serial 79349587
JIXING
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Feb 13, 2024
- Examiner
- ABRAMS, JACQUELINE WILLETTE
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with JIXING?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Ji Xing Pharmaceuticals (Shanghai) Co., Ltd.
CN
Other trademarks owned by Ji Xing Pharmaceuticals (Shanghai) Co., Ltd.
Ji Xing Pharmaceuticals (Shanghai) Co., Ltd.
CN
Other trademarks owned by Ji Xing Pharmaceuticals (Shanghai) Co., Ltd.
Ji Xing Pharmaceuticals (Shanghai) Co., Ltd.
CN
Other trademarks owned by Ji Xing Pharmaceuticals (Shanghai) Co., Ltd.
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Michael T. Smith
Michael T. Smith Birch Stewart Kolasch & Birch LLP8110 Gatehouse Road, Suite 100EFalls Church, VA 22042UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Antibiotics for human use; anti-allergic and pain reduction medicines for treatment of illnesses for human purposes; Medicines for the treatment of cardiovascular and cerebrovascular diseases for human use; anti-inflammatories for human use; ocular pharmaceuticals for human use; pharmaceutical preparations for the treatment of cardiovascular diseases and disorders, ophthalmic diseases and disorders, respiratory diseases and disorders, hyperlipidemia, hypertension, pulmonary hypertension, cancer, diabetes, infectious diseases, hypercholesterolemia, allergies, inflammation, cerebrovascular diseases and pain; chemico-pharmaceutical preparations for the treatment of cardiovascular diseases and disorders, ophthalmic diseases and disorders, respiratory diseases and disorders, hyperlipidemia, hypertension, pulmonary hypertension, cancer, diabetes, infectious diseases, hypercholesterolemia, allergies, inflammation, cerebrovascular diseases and pain; ; antibiotic, sunburn, anti-inflammatory ointments for pharmaceutical purposes; bronchodilating preparations; injectable pharmaceuticals for treatment of inflammation; Medicinal preparations for the mouth to be applied in the form of tablets and compressed tablets; Tincture of iodine; Herbal tinctures for medical purposes; collyrium for human purposes; seawater for medicinal bathing for human purposes; medicated lotions for treating dermatological conditions for human purposes; pharmaceutical products for the treatment of infectious diseases; pharmaceutical preparations for the treatment of hypercholesterolemia; pharmaceutical preparations for the treatment of hyperlipidemia; pharmaceutical preparations for the treatment of asthma; cholesterol reducers; antihypertensives; anti-diabetic pharmaceuticals; anti-diabetic preparations; antiarrhythmics; cardiovascular pharmaceutical preparations; pharmaceutical preparation for eye or intraocular surgery; ophthalmic preparations; medical preparations for use with eyes; medicines for the treatment of cardiovascular diseases; pharmaceutical preparations for inhalation for the treatment of pulmonary hypertension; depuratives for the body; Anti-infective products for veterinary use; Veterinary preparations, namely, pain relief medication; medicines for treatment of inflammation for veterinary purposes; biocides; disinfectant wipes; teething gels; diapers for pets; pharmaceutical candy | ACTIVE | — |
| 010 | Medical apparatus and instruments for monitoring vital signs, blood properties and respiratory events; Surgical apparatus and instruments for medical use; Surgical apparatus and instruments for dental use; radiological apparatus for medical purposes; belts for medical purposes; spoons for administering medicine; sanitary masks; protective masks for medical purposes; feeding bottles;Intra-uterine contraceptive devices; Diaphragms for contraception; artificial heart valves; Orthopedic support bandages; Plaster casts for orthopedic purposes; Vertebral orthopedic apparatus; Orthopedic supports; suture materials | ACTIVE | — |
| 035 | Advertising services; professional business consultancy; Promotional marketing services; Marketing research services; Marketing advisory services; personnel management consultancy; administrative services for the relocation of businesses; word processing; Retail and wholesale store services in the field of drugs, medicinal preparations, medical supplies and sanitary preparations | ACTIVE | — |
| 042 | Scientific research and development; development of pharmaceutical preparations and medicines; biomedical research services; medical research services; chemical research; biotechnology research; Software as a service (SAAS) services featuring software for analyzing and reporting self-assessment of illness; Software as a service (SAAS) services, namely, hosting software for use by others for use in database management, use as a spreadsheet, word processing; pharmaceutical drug development services; pharmaceutical drug research services | ACTIVE | — |
| 044 | Health care; medical assistance; medical consultations; telemedicine services; Physical therapy in the nature of movement therapy; Occupational therapy services; medical analysis services for diagnostic and treatment purposes provided by medical laboratories; medical screening; provision of medical information; health counseling | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Ji Xing Pharmaceuticals (Shanghai) Co., Ltd.
- Other trademarks owned by Ji Xing Pharmaceuticals (Shanghai) Co., Ltd.
- Other trademarks owned by Ji Xing Pharmaceuticals (Shanghai) Co., Ltd.
- Other trademarks in Class 005
- Other trademarks in Class 010
- Other trademarks in Class 035
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named JIXING
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jun 11, 2024 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| May 16, 2024 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| May 16, 2024 | FIMP | FINAL DISPOSITION PROCESSED | — |
| May 13, 2024 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Feb 13, 2024 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Feb 13, 2024 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Nov 28, 2023 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Nov 28, 2023 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Nov 27, 2023 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Nov 8, 2023 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Nov 8, 2023 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Nov 8, 2023 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Oct 17, 2023 | PBCR | WITHDRAWN FROM PUB - OG REVIEW QUERY | — |
| Sep 29, 2023 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Sep 29, 2023 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Sep 29, 2023 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Sep 29, 2023 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Sep 29, 2023 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Sep 28, 2023 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Sep 28, 2023 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 28, 2023 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 20, 2023 | RFNT | REFUSAL PROCESSED BY IB | — |
| Mar 28, 2023 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Mar 28, 2023 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Mar 25, 2023 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Feb 2, 2023 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Feb 1, 2023 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 31, 2023 | RFWR | NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW | — |
| Dec 4, 2022 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Dec 3, 2022 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 3, 2022 | DOCK | ASSIGNED TO EXAMINER | — |
| Sep 20, 2022 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Sep 16, 2022 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Sep 15, 2022 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |